Long-Term Adherence to Direct Oral Anticoagulants in Patients with Atrial Fibrillation: A Comparative Cross-Sectional Study

被引:3
|
作者
Gulpen, Anouk J. W. [1 ,2 ,3 ]
Braeken, Dionne C. W. [1 ]
Schalla, Simon [2 ,4 ]
Ten Cate, Hugo [1 ,2 ,3 ]
Crijns, Harry J. [2 ,4 ]
Ten Cate-Hoek, Arina J. [1 ,2 ]
机构
[1] Maastricht & Lab Clin Thrombosis & Hemostasis, Thrombosis Expert Ctr, Maastricht, Netherlands
[2] Cardiovasc Res Inst Maastricht CARIM, Maastricht, Netherlands
[3] Maastricht Univ, Dept Internal Med, Med Ctr, Maastricht, Netherlands
[4] Maastricht Univ, Med Ctr, Dept Cardiol & Radiol, Maastricht, Netherlands
关键词
Direct oral anticoagulants; Thrombosis; Adherence; WARFARIN; DABIGATRAN; PERSISTENCE; APIXABAN; THERAPY; SCALE;
D O I
10.1159/000524094
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background: Long-term treatment with direct oral anticoagulants (DOAC) is required for the majority of patients with nonvalvular atrial fibrillation (AF) to prevent ischemic stroke and systemic embolism. Adherence to therapy may impact clinical outcomes. Therefore, the purpose of this study was to assess the potential impact of structured follow-up on long-term adherence to DOAC therapy compared to standard care. Methods: This is a cross sectional study on the implementation phase of medication adherence to DOACs, comparing patients with AF following completion of structured follow-up of minimally 1 year with those who received standard care. All patients used DOACs for more than 2 years and completed a questionnaire on adherence. Adherence was measured with the Morisky Medication Adherence Scale-8 (MMAS-8) score and assessed via an online web portal. Results: A total of 212 patients were included. The mean MMAS-8 score was 7.55 (SD 0.93) after structured follow-up and 7.25 (SD 1.01) for standard care; p = 0.045. Following structured follow-up 64.1% of patients had a high adherence (MMAS score of 8) compared to 50% receiving standard care; p = 0.05. Patients following structured follow-up on a once daily DOAC regime had higher MMAS-8 scores compared to those on a twice daily regime; 7.74 (SD 0.74) versus 7.00 (SD 1.22); p < 0.001. The rates of minor bleedings were 10.6% versus 21.4% respectively, p = 0.038. Conclusion: In patients on long-term DOAC treatment, adherence to therapy was significantly increased after receiving an initial period of structured follow-up compared to standard care. Additionally, adherence to DOAC therapy was higher with once-daily treatment regimen. Significant more minor bleedings were reported in the standard care group. These results indicate that implementation of structured follow-up of patients with AF using DOACs merits further evaluation. (c) 2022 The Author(s). Published by S. Karger AG, Basel
引用
收藏
页码:476 / 483
页数:8
相关论文
共 50 条
  • [41] Relationship of health literacy and adherence to oral anticoagulation therapy in patients with atrial fibrillation: a cross-sectional study
    Bartolazzi, Frederico
    Ribeiro, Antonio Luiz Pinho
    de Sousa, Waleska Jaclyn Freitas Nunes
    Vianna, Mayara Sousa
    da Silva, Jose Luiz Padilha
    Martins, Maria Auxiliadora Parreiras
    JOURNAL OF THROMBOSIS AND THROMBOLYSIS, 2021, 52 (04) : 1074 - 1080
  • [42] Comparison of Drug Switching and Discontinuation Rates in Patients with Nonvalvular Atrial Fibrillation Treated with Direct Oral Anticoagulants in the United States
    Baker, Christine L.
    Dhamane, Amol D.
    Mardekian, Jack
    Dina, Oluwaseyi
    Russ, Cristina
    Rosenblatt, Lisa
    Lingohr-Smith, Melissa
    Menges, Brandy
    Lin, Jay
    Nadkarni, Anagha
    ADVANCES IN THERAPY, 2019, 36 (01) : 162 - 174
  • [43] Secondary adherence to non-vitamin-K antagonist oral anticoagulants in patients with atrial fibrillation in Sweden and the Netherlands
    Jacobs, Maartje S.
    Schouten, Jeroen F.
    de Boer, Pieter T.
    Hoffmann, Mikael
    Levin, Lars-Ake
    Postma, Maarten J.
    CURRENT MEDICAL RESEARCH AND OPINION, 2018, 34 (10) : 1839 - 1847
  • [44] Efficacy and Safety of Direct Oral Anticoagulants in Elderly Patients With Atrial Fibrillation: A Network Meta-Analysis
    Deng, Kaisheng
    Cheng, Jinqun
    Rao, Shufang
    Xu, Huafu
    Li, Lixia
    Gao, Yanhui
    FRONTIERS IN MEDICINE, 2020, 7
  • [45] Effectiveness and safety of direct oral anticoagulants versus warfarin in patients with atrial fibrillation and advanced kidney disease
    Hsu, Chia-Chen
    Chen, Cheng-Chi
    Chou, Chian-Ying
    Chen, Kuan-Hsuan
    Wang, Sheng-Fan
    Chang, Shih-Lin
    Chang, Yuh-Lih
    JOURNAL OF THROMBOSIS AND THROMBOLYSIS, 2023, 56 (04) : 518 - 528
  • [46] Adherence is an optimal factor for maximizing the effective and safe use of oral anticoagulants in patients with atrial fibrillation
    Yang, So-Young
    Kang, Dong-Won
    Nam, Jin Hyun
    Choi, Eue-Keun
    Lee, Eui-Kyung
    Shin, Ju-Young
    Kwon, Sun-Hong
    SCIENTIFIC REPORTS, 2022, 12 (01)
  • [47] Safety of Using Direct Oral Anticoagulants in Patients with Atrial Fibrillation and Chronic Kidney Disease
    Petrov, Vladimir, I
    Shatalova, Olga, V
    Gerasimenko, Anastasia S.
    Gorbatenko, Vladislav S.
    RATIONAL PHARMACOTHERAPY IN CARDIOLOGY, 2019, 15 (04) : 530 - 537
  • [48] Stroke Incidence and Death in Atrial Fibrillation Patients Newly Treated with Direct Oral Anticoagulants
    Gabet, Amelie
    Chatignoux, Edouard
    Grave, Clemence
    Vallee, Alexandre
    Tuppin, Philippe
    Bejot, Yannick
    Olie, Valerie
    CLINICAL EPIDEMIOLOGY, 2021, 13 : 131 - 140
  • [49] Novel bleeding risk score for patients with atrial fibrillation on oral anticoagulants, including direct oral anticoagulants
    Adam, Luise
    Feller, Martin
    Syrogiannouli, Lamprini
    Del-Giovane, Cinzia
    Donze, Jacques
    Baumgartner, Christine
    Segna, Daniel
    Floriani, Carmen
    Roten, Laurent
    Fischer, Urs
    Aeschbacher, Stefanie
    Moschovitis, Giorgio
    Schlapfer, Jurg
    Shah, Dipen
    Amman, Peter
    Kobza, Richard
    Schwenkglenks, Matthias
    Kuehne, Michael
    Bonati, Leo H.
    Beer, Jurg
    Osswald, Stefan
    Conen, David
    Aujesky, Drahomir
    Rodondi, Nicolas
    JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2021, 19 (04) : 931 - 940
  • [50] Association between Cerebral Infarction Risk and Medication Adherence in Atrial Fibrillation Patients Taking Direct Oral Anticoagulants
    Akagi, Yuuki
    Iketaki, Akiko
    Nakamura, Reiko
    Yamamura, Shigeo
    Endo, Minori
    Morikawa, Keisuke
    Oikawa, Shun
    Ohta, Takahiro
    Tatsumi, Shimpei
    Suzuki, Takafumi
    Mizushima, Atsuhiro
    Koido, Keiichi
    Takahashi, Tatsuya
    HEALTHCARE, 2021, 9 (10)